A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)
Clinical trial NCT00891020 · COMPLETED
Trial details
- NCT number
- NCT00891020
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2010-07-01
- Enrollment
- 886
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.